TAL DAGAN

Allopathic & Osteopathic Physicians|Otolaryngology|Facial Plastic Surgery NEW YORK, NY NPI 1013997980

General Payments — all program years on this page

$3,941.67

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 50
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $381.49 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $381.4919

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
GlaxoSmithKline, LLC. $185.2212
GENZYME CORPORATION $153.835
Inspire Medical Systems, Inc. $25.411
Advanced Oxygen Therapy Inc. $17.031

By program year

Program yearAmountRecords
2018 $262.065
2019 $59.373
2020 $39.592
2021 $2,746.281
2022 $189.3911
2023 $263.499
2024 $381.4919

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1115778393 GlaxoSmithKline, LLC. $16.19 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116025702 GlaxoSmithKline, LLC. $17.86 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116175042 GlaxoSmithKline, LLC. $14.18 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116229735 GlaxoSmithKline, LLC. $30.05 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116272980 GlaxoSmithKline, LLC. $28.04 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116424011 GlaxoSmithKline, LLC. $10.26 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116439613 GlaxoSmithKline, LLC. $9.03 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116454949 GlaxoSmithKline, LLC. $1.46 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116534070 GlaxoSmithKline, LLC. $26.28 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116591401 GlaxoSmithKline, LLC. $5.88 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116631142 GlaxoSmithKline, LLC. $13.20 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116736246 GlaxoSmithKline, LLC. $12.79 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140009564 GENZYME CORPORATION $30.85 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140009566 GENZYME CORPORATION $31.10 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140009570 GENZYME CORPORATION $37.41 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140009574 GENZYME CORPORATION $18.95 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140009582 GENZYME CORPORATION $35.52 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143010836 Advanced Oxygen Therapy Inc. $17.03 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148049842 Inspire Medical Systems, Inc. $25.41 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.